Pluri Inc. (PLUR)
NASDAQ
Closed
Sep 21, 2026
Day's Range
1.0152 wk Range
1.01Profile - PLUR - Pluri Inc.
Profile
Mic Code
XNCM
Sector
Healthcare
Industry
Biotechnology
Employees
92
Pluri Inc. is a biotechnology company focused on the research, development, manufacturing, and commercialization of cell-based products and related technologies. The company uses its proprietary three-dimensional cell expansion platform to support scalable cell production for applications across regenerative medicine, immunotherapy, food technology, and agricultural technology. Its current business areas include cell therapeutics, cultivated food solutions, and contract development and manufacturing services, reflecting a diversified platform built around advanced cell engineering. Pluri Inc. serves markets that rely on biological innovation to address medical, industrial, and sustainability challenges, positioning itself as a provider of cell-based solutions for both therapeutic and non-therapeutic uses. Headquartered in Haifa, Israel, Pluri Inc. operates as a clinical-stage biotechnology company with a focus on translating cell technology into practical commercial products and services.
Profile Details
Type
Common Stock
Address
MATAM Advanced Technology Park
City
Haifa
Zip
3508409
Country
Israel
Phone
972 74 710 8600
Key Executives - PLUR - Pluri Inc.
Key executives
Cross Listings - PLUR - Pluri Inc.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
